Clinical Trial Detail

NCT ID NCT02573363
Title Selinexor With Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors University of Chicago
Indications

acute myeloid leukemia

Therapies

Cytarabine

Mitoxantrone

Selinexor

Age Groups: adult

No variant requirements are available.